The Pradaxa lawsuit has inspired the lawsuits against Xarelto’s manufacturer for similar injuries sustained. Both drugs were designed, developed, and marketed as better alternatives to Coumedin. The main benefit was eliminating the requirement of constant blood tests which was both time-consuming and annoying for patients. Since both drugs were created, internal bleeding and even death...
Pradaxa patients may have a better chance of surviving emergency surgeries, due to a recent study using 5g of idarucizumab (humanized antibody fragments). In critical cases, such as patients with uncontrolled bleeding, intracranial hemorrhage, or severe trauma following an automobile accident, there is a marginally improved chance for the patient to survive invasive procedures. The specific study...
Although there is still no antidote for Xarelto or Eliquis, the European Medicines Agency (EMA) is fast-tracking Praxbind as an antidote for the blood thinner Pradaxa. Pradaxa patients have been injured and dying due to the anticoagulant causing uncontrollable bleeding in emergencies. The life-threatening risk of uncontrolled bleeding is a constant threat to Pradaxa patients....
The Washington Post published an article recently reporting concerns that the FDA did not adequately review the safety and risks of the Pradaxa blood thinner. Reports of Pradaxa injuries are coming in daily to our office, including an Indiana man who has been taking Pradaxa since 2013, and now has blood in his urine, a Vermont woman...
Pradaxa is a prescription blood thinner medicine that lowers the chance of blood clots forming in your body. It is commonly prescribed to reduce the risk of stroke and blood clots in patients with Atrial Fibrillation that is not caused by a heart valve problem. Pradaxa is also used to treat blood clots in the veins...
A new generation of anticoagulants, namely Xarelto and Pradaxa, have been at the center of much controversy in recent times. The manufacturers of these drugs have seen a significant increase in sales of their drugs, thanks in part to how convenient they are compared to more traditional blood thinners. However, the significant sales of these drugs...
A new experimental drug has been proven to reverse the effects of the drug Pradaxa (dabigatran). The drug, called idarucizumab, is said to work within minutes of being given to patients. Pradaxa is a newer anticoagulant that has been marketed as an easier alternative to traditional blood thinners. Unfortunately, it was not created alongside an...
Press Room
